NCHR Testimony on Ablatherm High-Intensity Focused Ultrasound Device

July 30, 2014. Prostate cancer is a very common cancer and all the current treatments have serious side effects that harm men’s quality of life. The question today is whether the Ablatherm high-intensity focused ultrasound device is safe and effective for the treatment of low-risk, localized prostate cancer. Most men diagnosed with localized, low-risk prostate cancer will not die from prostate cancer, but from something else.

Read More »

NCHR Comments Urging FDA to Provide Higher Standards And Upclassify Surgical Mesh For POP And Incontinence

July 30, 2014. On behalf of the National Center for Health Research, I am pleased to have the opportunity to express our views on the proposed order on the reclassification of certain surgical mesh devices and surgical instruments. Our nonprofit Center analyzes and reviews research on a range of treatment issues, and provides objective and understandable information to patients and providers.

Read More »